The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
Prokarium: Leading the Evolution of Bacterial Immunotherapy, the Next Frontier in Cancer Treatment• Claude Discovers Novel Enzyme System with CRISPR-like Repeats• New Clinical Study Aims to Find Out if FMT capsules could help better manage anorexia• MaaT Pharma Provides Update on MaaT013 (Xervyteg®) Potential Development Plan Following CHMP Negative Opinion After Re-examination• Evvy Raises $40M Series B to Scale AI-Powered Precision Diagnostics & Care Platform for Women’s Health• Armata Pharmaceuticals Receives U.S. FDA Breakthrough Therapy Designation for AP-SA02•

Category: Pharma & Human Health

University of Pittsburgh lab shows phage attacks in new light
Infectious Disease & AMR

University of Pittsburgh lab shows phage attacks in new light

MAR 8, 2023
Colorectal cancer surgery: Gut microbiota helps healing
Gastrointestinal

Colorectal cancer surgery: Gut microbiota helps healing

MAR 8, 2023
Biose Industrie announces the opening of new manufacturing development facility in Boston, MA
Finance

Biose Industrie announces the opening of new manufacturing development facility in Boston, MA

MAR 2, 2023
Biose Industrie to receive €80M in investment to boost workforce and manufacturing capabilities
Finance

Biose Industrie to receive €80M in investment to boost workforce and manufacturing capabilities

FEB 17, 2023
Regulatory pathway needs to be developed to make the most of phages
Pharma & Human Health

Regulatory pathway needs to be developed to make the most of phages

FEB 16, 2023
Prokarium Announces $30 Million Financing to Deliver Lead Program into Clinic and Build Novel Therapeutic Platform
Finance

Prokarium Announces $30 Million Financing to Deliver Lead Program into Clinic and Build Novel Therapeutic Platform

FEB 10, 2023
ADM Opens More Than $30 Million State-of-the-Art Production Facility in Spain
Finance

ADM Opens More Than $30 Million State-of-the-Art Production Facility in Spain

FEB 8, 2023
Call for Experts – A Survey on Microbiome-Based Biomarker Development
Pharma & Human Health

Call for Experts – A Survey on Microbiome-Based Biomarker Development

FEB 7, 2023
MD Anderson and Federation Bio to Develop Novel Microbiome Treatment for Patients with Immunotherapy-Resistant Cancers
Oncology

MD Anderson and Federation Bio to Develop Novel Microbiome Treatment for Patients with Immunotherapy-Resistant Cancers

FEB 2, 2023
“Probiotics” Green-lit for market-usage by French Authorities
Biotics and Supplements

“Probiotics” Green-lit for market-usage by French Authorities

JAN 25, 2023
Finch Therapeutics Announces Decision to Discontinue Phase 3 Trial of CP101
Clinical & Manufacturing

Finch Therapeutics Announces Decision to Discontinue Phase 3 Trial of CP101

JAN 24, 2023